Elena Galvani
Alderley Park
Manchester, ENG, United Kingdom
Manchester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Correction: Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Journal: Breast cancer research and treatment
Published: January 24, 2026
Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.
Journal: Cancer discovery
Published: December 18, 2025
Bayesian modeling for analyzing heterogeneous response in preclinical mouse tumor models.
Journal: Science translational medicine
Published: October 30, 2024
Efficacy and pharmacodynamic effect of anti-CD73 and anti-PD-L1 monoclonal antibodies in combination with cytotoxic therapy: observations from mouse tumor models.
Journal: Cancer biology & therapy
Published: January 11, 2024
Tumour infiltrating B cells discriminate checkpoint blockade-induced responses.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 06, 2022
T cell immune awakening in response to immunotherapy is age-dependent.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 10, 2021
Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.
Journal: Nature communications
Published: July 23, 2021
Novel non-terminal tumor sampling procedure using fine needle aspiration supports immuno-oncology biomarker discovery in preclinical mouse models.
Journal: Journal for immunotherapy of cancer
Published: May 24, 2021
Immune-awakening revealed by peripheral T cell dynamics after one cycle of immunotherapy.
Journal: Nature cancer
Published: February 29, 2020
Brain microenvironment-driven resistance to immune and targeted therapies in acral melanoma.
Journal: ESMO open
Published: February 11, 2020
Stroma remodeling and reduced cell division define durable response to PD-1 blockade in melanoma.
Journal: Nature communications
Published: November 21, 2019
Last Updated: 09/26/2026